MAP Pharmaceuticals, Inc.

• About Us 
  • Message from the CEO
  • Management Team
  • Board of Directors
  • Partnering
  • Contact Us
• Product Pipeline 
  • Pediatric Asthma Therapy
  • Inhaled Migraine Therapy
  • Asthma/COPD Therapy
  • Inhaled Diabetes Therapy
• Investor Relations 
  • IR Home
  • Press Releases
  • Calendar of Events
  • Corporate Governance
  • Management
  • Board of Directors
  • Committee Composition
  • Annual Reports
  • SEC Filings
  • Stock Information
  • Analyst Coverage
  • Contact Us
• Science & Technology 
• Publications 
  • Asthma
  • Migraine
  • Aerosol Science and Technology

Investor Relations

Print page     Email page

Annual Reports

2007 Annual Report [ PDF, 1.2 MB ]

= add file to Briefcase

Stock Information

NASD:MAPP $9.95	- 0.50
Aug 28, 2008	1:43 PM ET

Quotes delayed at least 20 minutes.
Information provided by TurboFeed.